Histopathological assessment of lymph nodes in upper gastrointestinal cancer: Does triple levelling detect significantly more metastases?

Journal of Clinical Pathology

Volumn 60, Issue 11, 2007, Pages 1222-1225

  McGrath, Stephen ^b   Cross, Sarah ^c   Pritchard, Susan Anne ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c Schering Health Care   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FALSE NEGATIVE REACTIONS; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 36048970142     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.045518     Document Type: Article

References (26)

1. www.cancerresearchuk.org (accessed September 2006).
2. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
3. Sbin L, Wittekina C, eds. TNM classification of malignant tumours. 6th edn. New York: Wiley-Liss, 2002:60-8.
4. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95:1434-43.
5. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-9.
6. Kendal WS. Lymph node-based prognostics: limitations with individualized cancer treatment. Am J Clin Oncol 2006;29:298-304.
7. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-61.
8. Dixon A. Standards and minimum data sets for reporting common cancers: gastric cancer. London: The Royal College of Pathologists, April 2000.
9. Mapstone NP. Standards and minimum data sets for reporting common cancers: oesophageal cancer. London: The Royal College of Pathologists, November 1998.
10. Novelli MR. Dataset for the histopathological reporting of gastric carcinoma, 2nd edn, draft. London: The Royal College of Pathologists, June 2006.
11. Mapstone NP. Dataset for the histopathological reporting of oesophageal carcinoma, 2nd edn, draft. London: The Royal College of Pathologists, May 2006.
12. Ibrahim NBN. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. J Clin Pathol 2000;53:89-94.
13. Lee RG, Compton CC. Protocol for the examination of specimens removed from patients with oesophageal cancer. A basis for checklist. The Cancer Committee, College of American Pathologists and the Task Force on the Examination of Specimens from Patients with Esophageal Cancer. Arch Pathol Lab Med 1997;121:925-9.
14. NHSBSP. Pathology reporting in breast cancer screening, Publication no 3. Sheffield: NHSBSP Publications, 1995 (revised 1997).
15. NHSBSP. Pathology reporting of breast disease, Publication no 58. Sheffield: NHSBSP Publications, January 2005.
16. Verrill C, Carr NJ, Wilkinson-Smith E, et al. Histopathological assessment of lymph nodes in colorectal carcinoma: does triple levelling detect significantly more metastases? J Clin Pathol 2004;57:1165-7.
17. Yasuda K, Adachi Y, Shiraishi N, et al. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002;9:771-4.
18. Bonavina L, Ferrero S, Midolo V, et al. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg 1999;3:468-76.
19. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;86:1883-5.
20. Sato F, Shimada Y, Li Z, et al. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001;88:426-32.
21. Nakamura T, Ide H, Eguchi R, et al. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol 2002;79:224-9.
22. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumour cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 2000;89:1874-82.
23. Tachibana M, Yoshimura H, Kinugasa S, et al. Clinicopathological factors correlated with number of metastatic lymph nodes in oesophageal cancer. Digest Liver Dis 2001;33:534-8.
24. Dhar DK, Kubota N, Kinukawa N, et al. Prognostic significance of metastatic lymph node size in patients with gastric cancer. Br J Surg 2003;90:1522-30.
25. Komori T, Doki Y, Kabuto T, et al. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers. J Surg Oncol 2003;82:19-27.
26. Doi N, Imada T, Aoyama N, et al. Prognostic significance of the carcinoma area in the thickest part of the lymph node. Hepatogastroenterology 2000;47:728-32.